Myriad Genetics Inc (NASDAQ:MYGN)
| 22.52 Delayed Data As of Mar 30 |  -0.80 / -3.43%Today’s Change | 13.92 Today|||52-Week Range 28.18 | +55.20% Year-to-Date |
Latest MYGN News | Press Releases
No recent news for Myriad Genetics Inc.
Today’s Trading
| Previous close | 23.33 |
| Today’s open | 23.33 |
| Day’s range | 22.46 - 23.66 |
| Volume | 446,047 |
| Average volume (3 months) | 696,156 |
| Market cap | $1.9B |
Data as of 3:59pm ET, 03/30/2023
Growth & Valuation
| Earnings growth (last year) | -298.51% |
| Earnings growth (this year) | -10.00% |
| Earnings growth (next 5 years) | -68.57% |
| Revenue growth (last year) | -1.77% |
| P/E ratio | NM |
| Price/Sales | 1.72 |
| Price/Book | 2.17 |
Competitors
Data as of 3:59pm ET, 03/30/2023
Financials
| Next reporting date | May 4, 2023 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $678.4M |
| Annual profit (last year) | -$112.0M |
| Net profit margin | -16.51% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Salt Lake City, Utah |
Forecasts
